Loading...

Loading...


Loading...

Loading...


Data from GISAID Initiative. Note, that it is important not to assume that shown data are necessarily representative of the all region due to a potential non uniform sampling.

Loading...
per 1e5 inhabitant correction

Loading...


Notes for a correct interpretation

• Sampling may not be uniform within the different autonomous communities. Therefore, it is important not to assume that the counts/frequencies shown are necessarily representative of the region.
• The charts used are based on the sample collection date, and sequencing or GISAID submission date. As a result, this date may differ from when the sample was processed and sequenced, and when the data is released to the public.
• In relation with the last consideration, last data pints often has incomplete data and may change as more sequences come in.
• The mutations that define SARS-CoV-2 (CoV-19) lineages are updated every few days. Therefore, displayed data is susceptible to change over time.

Acknowledgements

We are grateful to the data contributors who shared the data used in this Web Application via the GISAID Initia-tive*: the Authors, the Originating Laboratories responsible for obtaining the specimens, and the Submitting Laboratories that generated the genetic sequences and metadata.
* (a) Elbe, S., and Buckland-Merrett, G. (2017) Data, disease and diplomacy: GISAID’s innovative contribution to global health. Global Challenges, 1:33-46. DOI: 10.1002/gch2.1018 PMCID: 31565258 (b) Shu, Y., McCauley, J. (2017) GISAID: From vision to reality. EuroSurveillance, 22(13) DOI: 10.2807/1560-7917.ES.2017.22.13.30494 PMCID: PMC5388101